Episode 23003
23-03 Dr. Rob Ross, CEO, Surface Oncology
Surface Oncology's strategy to improve on the first generation of immuno-oncology drugs. Their Phase 2 trials in lung cancer and liver cancer are underway and recruiting.
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
January 15, 202316m 14s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Surface Oncology's strategy to improve on the first generation of immuno-oncology drugs. Their Phase 2 trials in lung cancer and liver cancer are underway and recruiting.
Topics
biotechentrepreneurshipbioentrepreneurship